KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-cash Items (2020 - 2023)

Ginkgo Bioworks Holdings (DNA) has disclosed Non-cash Items for 4 consecutive years, with $14.6 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Non-cash Items fell 66.58% year-over-year to $14.6 million, compared with a TTM value of $14.6 million through Jun 2023, down 66.58%, and an annual FY2022 reading of $9.5 million, down 94.86% over the prior year.
  • Non-cash Items was $14.6 million for Q2 2023 at Ginkgo Bioworks Holdings, up from $11.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $386.0 million in Q4 2020 and bottomed at $9.5 million in Q4 2022.
  • Average Non-cash Items over 4 years is $117.5 million, with a median of $43.7 million recorded in 2022.
  • The sharpest move saw Non-cash Items plummeted 94.86% in 2022, then tumbled 40.76% in 2023.
  • Year by year, Non-cash Items stood at $386.0 million in 2020, then tumbled by 51.91% to $185.6 million in 2021, then tumbled by 94.86% to $9.5 million in 2022, then skyrocketed by 53.12% to $14.6 million in 2023.
  • Business Quant data shows Non-cash Items for DNA at $14.6 million in Q2 2023, $11.0 million in Q1 2023, and $9.5 million in Q4 2022.